Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Other

If ‘other’, further details on the scope of the study

Knowledge, Attitude, Behavior Survey
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Survey
Study drug and medical condition

Name of medicine, other

GATTEX

Study drug International non-proprietary name (INN) or common name

TEDUGLUTIDE

Anatomical Therapeutic Chemical (ATC) code

(A16AX08) teduglutide
teduglutide

Medical condition to be studied

Short-bowel syndrome
Population studied

Short description of the study population

Participants and prescriber who have completed Wave 7 of the GATTEX participant KAB Survey will be observed in this REMS survey.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

600
Study design details

Main study objective

The main aim of this study is to document the level of knowledge and assess attitudes and behaviors of both participants and physicians regarding the risks and safe use of GATTEX. The survey will be done via internet, telephone, or paper and both physicians and participants will be able to choose the method that is preferred.

Outcomes

Number of Participants and Prescribers Providing Correct Responses to Questions. Number of Participants and Prescribers Providing Correct Responses (80%) to and Demonstrated Understanding of Survey Knowledge Domains.

Data analysis plan

Detailed statistical analysis methods will be conducted as described in the SAP for this study. Data will be summarized with tabulated descriptive statistics: number of observations, minimum, maximum, mean, median, standard deviation, and range for continuous variables and counts and percentages for categorical variables. In addition, graphical data displays will be used to summarize selected data.